Zydus Lifesciences gains on getting USFDA’s approval for ‘Dapagliflozin Tablets’
Mumbai, April 8 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 884.35, up by 10.70 points or 1.22% from its previous closing of Rs. 873.65 on the BSE. The scrip opened at Rs. 910.80 and has touched a high and low of Rs. 910.80 and Rs. 879.90 respectively. So far 29876 shares were traded … Read more
